Search results
After Plunging -30.6% in 4 Weeks, Here's Why the Trend Might Reverse for Citius Pharmaceuticals,...
Zacks via Yahoo Finance· 1 year agoThe heavy selling pressure might have exhausted for Citius Pharmaceuticals, Inc. (CTXR) as it is...
Breakeven On The Horizon For Citius Pharmaceuticals, Inc. (NASDAQ:CTXR)
Simply Wall St. via Yahoo Finance· 8 months agoCitius Pharmaceuticals, Inc. (NASDAQ:CTXR) is possibly approaching a major achievement in its...
We Think Citius Pharmaceuticals (NASDAQ:CTXR) Needs To Drive Business Growth Carefully
Simply Wall St. via Yahoo Finance· 5 months agoWe can readily understand why investors are attracted to unprofitable companies. For example,...
Here's Why Citius Pharmaceuticals (NASDAQ:CTXR) Must Use Its Cash Wisely
Simply Wall St. via Yahoo Finance· 2 years agoJust because a business does not make any money, does not mean that the stock will go down. For...
Citius Pharmaceuticals Inc (CTXR) Reports Q1 2024 Financials and Progress in Clinical Trials
GuruFocus.com via Yahoo Finance· 3 months agoLiquidity: Citius Pharmaceuticals Inc (NASDAQ:CTXR) reported $20.3 million in cash and cash equivalents as of December 31, 2023. Shares Outstanding: As of December 31, 2023, there were 158,966,576 ...
Citius Pharma To Spinoff Late-Stage Oncology Asset Into New Publicly Traded Firm
Benzinga via Yahoo Finance· 2 years agoCitius Pharmaceuticals Inc (NASDAQ: CTXR) plans to form a new company (NewCo) focused on developing...
Citius Pharma Inks Clinical Collaboration For I/ONTAK Combo Regime in Solid Tumor Settings
Benzinga via Yahoo Finance· 2 years agoCitius Pharmaceuticals Inc (NASDAQ: CTXR) collaborated with the University of Pittsburgh for I/ONTAK...
Combination Therapy for Hemorrhoids: Citius' Combination Products Shows Meaningful Reduction In...
Benzinga via Yahoo Finance· 11 months agoCitius Pharmaceuticals Inc's (NASDAQ: CTXR) Halo-Lido, a topical treatment comprising lidocaine and...